Showing 521 - 540 results of 597 for search '"prostate cancer"', query time: 0.12s Refine Results
  1. 521

    Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate by Edgar Linden-Castro, Marcela Pelayo-Nieto, Alejandro Alias-Melgar, Daniel Espinosa-Perezgrovas, Ivan Ramirez-Galindo, Gabriel Catalan-Quinto

    Published 2014-01-01
    “…We report the case of a 64-year-old patient with ductal adenocarcinoma of the prostate, which progresses to castration-resistant prostate cancer, that was treated with abiraterone acetate with good clinical response, to our knowledge, the first case of ductal adenocarcinoma of the prostate in treatment with abiraterone acetate.…”
    Get full text
    Article
  2. 522

    Fenômeno sexless marriage, câncer de próstata e bioética by Bruno Vilalva Mestrinho, Vitória Marra da Motta Vilalva Mestrinho, Renata Verna Leal de Oliveira

    Published 2025-01-01
    “…Consultaram-se as bases PubMed, SciELO e Google Scholar e sites de grande circulação, por meio dos descritores prostate cancer, relationship intimacy, partner, sexless marriage e treatment. …”
    Get full text
    Article
  3. 523

    Computational evaluation on spectroscopic (FT-IR, Raman), electronic and biological, and NLO properties of cirsilineol by DFT, ADMET, and molecular docking method by Tirth Raj Paneru, Poonam Tandon, Bhawani Datt Joshi

    Published 2025-01-01
    “…This study aims to investigate the spectroscopic, electronic, and biological properties of drugs and predict their suitability for drug-like candidates to inhibit prostate cancer. The computational evaluation was performed with density functional theory (DFT) at B3LYP/6−311++G(d,p) level of theory and drug-like characteristics rendered from ADMET analysis. …”
    Get full text
    Article
  4. 524

    Computational evaluation on spectroscopic (FT-IR, Raman), electronic and biological, and NLO properties of cirsilineol by DFT, ADMET, and molecular docking method by Tirth Raj Paneru, Poonam Tandon, Bhawani Datt Joshi

    Published 2025-01-01
    “…This study aims to investigate the spectroscopic, electronic, and biological properties of drugs and predict their suitability for drug-like candidates to inhibit prostate cancer. The computational evaluation was performed with density functional theory (DFT) at B3LYP/6−311++G(d,p) level of theory and drug-like characteristics rendered from ADMET analysis. …”
    Get full text
    Article
  5. 525

    Chronic calcified subdural hematoma masquerading as hemorrhagic extra-axial mass: A case report and brief review of the literature by Musharaf Khan, DO, Subtain Ali, MD, Joe T. Joseph, MD, Sanjay Bhatia, MBBS, MS, MBChB, MBA, FAANS, DABA, Dhairya A. Lakhani, MD

    Published 2025-03-01
    “…A 73-year-old male with a history of prostate cancer, hypertension, and hyperlipidemia presented with vision changes and mild papilledema. …”
    Get full text
    Article
  6. 526

    Real Life Cancer Comorbidity in Greek Patients with Diabetes Mellitus Followed Up at a Single Diabetes Center: An Unappreciated New Diabetes Complication by Anastasia Thanopoulou, Demetrios Pectasides

    Published 2014-01-01
    “…Patients with cancer were older and more frequently smokers. Prostate cancer was the most frequent (24.0%) type. In T1DM cancer comorbidity was 3.0%. …”
    Get full text
    Article
  7. 527

    Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets? by Athina Kladi-Skandali, Kleita Michaelidou, Andreas Scorilas, Konstantinos Mavridis

    Published 2015-01-01
    “…The most prominent example of lncRNAs application in routine clinical practice is PCA3, a FDA-approved biomarker for prostate cancer. Regarding digestive system malignancies, the oncogenic HOTAIR is one of the most widely studied lncRNAs in the preclinical level and has already been identified as a potent prognostic marker for major malignancies of the gastrointestinal tract. …”
    Get full text
    Article
  8. 528

    General Approach to Identifying Potential Targets for Cancer Imaging by Integrated Bioinformatics Analysis of Publicly Available Genomic Profiles by Yongliang Yang, S. James Adelstein, Amin I. Kassis

    Published 2011-03-01
    “…We provide herein an example of identifying a tumor cell growth and proliferation subnetwork for prostate cancer. This systematic mining approach can be broadly applied to identify imaging or therapeutic targets for other human diseases.…”
    Get full text
    Article
  9. 529

    Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types by Jack D. Burton, David M. Goldenberg, Rosalyn D. Blumenthal

    Published 2008-01-01
    “…While preclinical activity has been observed in many cancer types, clinical activity has been observed only in pilot and phase II trials in liposarcoma and prostate cancer. Most studies address agonist compounds, with substantially fewer reports on anticancer effects of PPARγ antagonists. …”
    Get full text
    Article
  10. 530

    Treatment of Urethral Strictures from Irradiation and Other Nonsurgical Forms of Pelvic Cancer Treatment by Iyad Khourdaji, Jacob Parke, Avinash Chennamsetty, Frank Burks

    Published 2015-01-01
    “…Radiation therapy (RT), external beam radiation therapy (EBRT), brachytherapy (BT), photon beam therapy (PBT), high intensity focused ultrasound (HIFU), and cryotherapy are noninvasive treatment options for pelvic malignancies and prostate cancer. Though effective in treating cancer, urethral stricture disease is an underrecognized and poorly reported sequela of these treatment modalities. …”
    Get full text
    Article
  11. 531

    Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome Associated with Deletion of Chromosome 20q by Sukesh Manthri, Naresh K. Vasireddy, Sindhura Bandaru, Swati Pathak

    Published 2018-01-01
    “…A 73-year-old male with a history of prostate cancer presented to the hospital for evaluation of bleeding gums. …”
    Get full text
    Article
  12. 532

    NMD Microarray Analysis for Rapid Genome-Wide Screen of Mutated Genes in Cancer by Maija Wolf, Henrik Edgren, Aslaug Muggerud, Sami Kilpinen, Pia Huusko, Therese Sørlie, Spyro Mousses, Olli Kallioniemi

    Published 2005-01-01
    “…Such a “mutatomics” screening of prostate cancer cell lines led to the identification of inactivating mutations in the EPHB2 gene. …”
    Get full text
    Article
  13. 533

    Semantic Modeling for SNPs Associated with Ethnic Disparities in HapMap Samples by HyoYoung Kim, Won Gi Yoo, Junhyung Park, Heebal Kim, Byeong-Chul Kang

    Published 2014-03-01
    “…Our semantic modeling for ethnicity-specific SNPs showed interesting results in the three categories, including three diseases ("AIDS-associated nephropathy," "Hypertension," and "Pelvic infection"), one drug ("Methylphenidate"), and five pathways ("Hemostasis," "Systemic lupus erythematosus," "Prostate cancer," "Hepatitis C virus," and "Rheumatoid arthritis"). …”
    Get full text
    Article
  14. 534

    Role of S100 Proteins in Colorectal Carcinogenesis by Paula Moravkova, Darina Kohoutova, Stanislav Rejchrt, Jiri Cyrany, Jan Bures

    Published 2016-01-01
    “…Colorectal cancer is the third most common cancer in men (after lung and prostate cancer) and the second most frequent cancer in women (after breast cancer) worldwide. …”
    Get full text
    Article
  15. 535

    Doubling of Decipher Biopsy Genomic Score Is Related to Disease Reclassification on Subsequent Surveillance Biopsy but Not Adverse Features on Radical Prostatectomy by Kamyar Ghabili, Nathan Paulson, Jamil S. Syed, Cayce B. Nawaf, Ghazal Khajir, Darryl T. Martin, John Onofrey, Michael S. Leapman, Angelique Levi, Jeffrey C. Weinreb, Peter A. Humphrey, Preston C. Sprenkle

    Published 2021-01-01
    “…In a man on active surveillance for low-risk prostate cancer, a doubling of the Decipher biopsy score within genomic low-risk category from first to the second biopsy related to biopsy reclassification to Gleason grade group 4 on the third biopsy. …”
    Get full text
    Article
  16. 536

    Regulatory Role of the RUNX2 Transcription Factor in Lung Cancer Apoptosis by Camila Bernal, Andrea Otalora, Alejandra Cañas, Alfonso Barreto, Karol Prieto, Martin Montecino, Adriana Rojas

    Published 2022-01-01
    “…Current studies have confirmed that RUNX2 is closely related to the proliferation, invasion, and bone metastasis of multiple cancer types, such as osteosarcoma, breast cancer (BC), prostate cancer, gastric cancer, colorectal cancer, and lung cancer. …”
    Get full text
    Article
  17. 537

    Review of presentations and radiotherapy outcomes of patients with malignant spinal cord compression by Louisa M. Mbokazi, Sheynaz Bassa, Krishanthavathie Pillay

    Published 2025-01-01
    “…Results: Breast and prostate cancer were the most frequent primary disease sites. …”
    Get full text
    Article
  18. 538

    Cancer Mortality by Ethnicity in Colombia Between 2011 and 2022: A Population-Based Study by Maria Camila Urrea Suescun, Isabel C. Garcés-Palacio, Amr S. Soliman

    Published 2025-02-01
    “…Compared to the Mestizo population, Raizales and Afro-Colombians experienced disproportionately higher age-standardized mortality rates due to prostate cancer (26.6/100,000 and 8.6/100,000 vs. 8.1/100,000), and for Raizales and Rom breast cancer (14.0/100,000 and 103.2/100,000 vs. 9.1/100,000).ConclusionThe disparities in cancer mortality in ethnic minorities in Colombia call for investigating cancer etiology and access to care among the Rom and the Raizal populations.…”
    Get full text
    Article
  19. 539

    Purine-rich element binding protein alpha: a DNA/RNA binding protein with multiple roles in cancers by Shiyi Yu, Chengyang Jiang, Yawen Yang, Fei Cheng, Fangchen Liu, Chang Liu, Xue Gong

    Published 2025-01-01
    “…PURα was initially recognized as a tumor suppressor in acute myeloid leukemia (AML) and prostate cancer (PC). Most recently, several studies have revealed that PURα is dysregulated in multiple cancers, such as breast cancer (BC) and esophageal squamous cell carcinoma (ESCC). …”
    Get full text
    Article
  20. 540

    The effect between metabolic syndrome and life expectancy after cancer diagnosis: Catalan cohort study by Tomàs López-Jiménez, Oleguer Plana-Ripoll, Talita Duarte-Salles, Anna Palomar-Cros, Diana Puente

    Published 2025-01-01
    “…RLE varied by cancer type, with the highest RLE in men seen in prostate cancer and in women in non-Hodgkin lymphoma. …”
    Get full text
    Article